Stocks and Investing Stocks and Investing
Tue, August 13, 2024
Mon, August 12, 2024

Gavin Clark-Gartner Maintained (CABA) at Buy with Decreased Target to $15 on, Aug 12th, 2024


Published on 2024-10-28 13:35:26 - WOPRAI, Gavin Clark-Gartner
  Print publication without navigation


Gavin Clark-Gartner of Evercore ISI Group, Maintained "Cabaletta Bio, Inc." (CABA) at Buy with Decreased Target from $25 to $15 on, Aug 12th, 2024.

Gavin has made no other calls on CABA in the last 4 months.



There are 3 other peers that have a rating on CABA. Out of the 3 peers that are also analyzing CABA, 0 agree with Gavin's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Gavin


  • Douglas Tsao of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $25 on, Friday, August 9th, 2024
  • Josh Schimmer of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $50 on, Friday, June 21st, 2024
  • Ben Burnett of "Stifel" Maintained at Strong Buy and Held Target at $32 on, Monday, June 17th, 2024
Contributing Sources